Skip to main content

Use of formalin-fixed paraffin-embedded tumor tissue as a DNA source in molecular epidemiological studies of pediatric CNS tumors.

Ferguson AE, Cohn RJ, Ashton LJ

Publication: Diagn Mol Pathol (2012) • Vol 21 • Page 105-13PMID: 22555093View on PubMed

Purpose

The purpose of this paper was to compare DNA fragmentation, genotyping success rates, and whole genome amplification (WGA) between DNA extracted from fifty matched formalin-fixed paraffin-embedded (FFPE) and frozen central nervous system tumors.

Conclusion

FFPE DNA was generally more fragmented and had a higher real-time PCR cycle threshold (CT) than DNA isolated from frozen specimens. FFPE DNA failed to amplify with WGA kits and led to inconsistent and nonconcordant genotyping results for 2 deletion polymorphism assays, while GSTP1 and MTHFR polymorphisms were genotyped with 100% success in both FFPE and frozen specimens.

Studies (1)

Purpose

The purpose of this study was to compare DNA fragmentation, genotyping success rates, and WGA between DNA extracted from fifty matched FFPE and frozen central nervous system biopsies. 2-3 mm2 specimens stored frozen at -80 degrees C were compared to 10 5 uM FFPE sections that had been fixed for less than 48 h. DNA extraction from specimens weighing more than 25 mg was performed with NucleoBond AXG 100 gravity column, but DNA from smaller specimens was extracted using QIAamp DNA Mini or Micro Kit. FFPE specimens were deparaffinized in xylene prior to extraction.

Summary of Findings

The authors report DNA extraction from FFPE specimens with the QIAamp kit required up to 3 days of proteinase K digestion. Real-time PCR amplification of a 295 bp fragment of Beta-actin was possible using all frozen specimens, but amplification was highly variable using FFPE specimens and occurred at much higher cycle numbers. While all DNA extracted from frozen specimens allowed for amplification of 600 bp fragments, only a few FFPE specimens yielded DNA from which 600 bp fragments could be amplified with the majority yielding maximum products of 200-300 bp. GenomiPhi amplification of DNA from frozen specimens yielded 200 fold amplification, but the authors report DNA from FFPE tissues failed to amplify with either GenomiPhi or GenomePlex whole genome amplification kits. GSTP1 and MTHFR polymorphisms were genotyped with 100% success in frozen and FFPE specimens, and 100% concordance in genotype between matched frozen and FFPE specimens was observed. Frozen specimens allowed for PCR success 100% of the time for the GSTM1 and GSTT1 deletion polymorphism assays, but in FFPE specimens, PCR detection of these deletions was successful in only 70% and 92% of specimens, respectively. Further, the genotype concordance for matched frozen and FFPE specimens was 77% for the GSTM1 assay and 82% for the GSTT1 assay due to decreased detection of the deletion. The authors report that repeated genotyping of FFPE specimens led to inconsistent results.

  • Biospecimens

    TissueBrain
  • Preservation Types

    FrozenFormalin
  • Diagnoses

    NeoplasticOther
  • Platforms

    DNAPCR
    DNAReal-time qPCR
    DNAWhole genome amplification
    DNASNP assay
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Astrocytoma
    Medulloblastoma
    Unspecified central nervous system tumor
    Biospecimen PreservationType of fixation/preservation
    Formalin (buffered)
    Frozen
    Whole genome amplification SpecificNucleic acid amplification
    GenomePlex
    GenomiPhi
    Real-time qPCR SpecificTargeted nucleic acid
    Beta actin
    SNP assay SpecificTargeted nucleic acid
    Del GSTM1
    Del GSTT1
    GSTP1 Ile105Val
    MTHFR 667 C>T
    PCR SpecificTargeted nucleic acid
    Multiplex assay